Keyphrases
PARP Inhibitor (PARPi)
100%
PJ34
100%
Angiogenesis Inhibition
100%
Vascular Endothelial Growth Factor
37%
Endothelial Cells
37%
Angiogenesis
37%
New Blood Vessel
25%
Blood Vessel Formation
25%
Wound Healing
12%
Angiogenic Factors
12%
Mitogen-activated Protein Kinase
12%
Cell Properties
12%
High Dose
12%
ERK2
12%
Pharmacological Agents
12%
Concentration-dependent
12%
Poly (ADP-ribose) Polymerase Inhibition
12%
Neovascularization
12%
In Vitro Incubation
12%
Multiple Signaling Pathways
12%
N,N-dimethylacetamide
12%
Being Observed
12%
Matrigel
12%
Capillary Morphogenesis
12%
NO Release
12%
Macular Degeneration
12%
Chicken Chorioallantoic Membrane
12%
Kinase Family
12%
NO-cGMP
12%
Pharmacology, Toxicology and Pharmaceutical Science
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase Inhibitor
100%
Vasculotropin
100%
Malignant Neoplasm
33%
Wound Healing
33%
Mitogen Activated Protein Kinase 3
33%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase
33%
Mitogen Activated Protein Kinase
33%
N,n Dimethylacetamide
33%
Matrigel
33%
Neovascularization (Pathology)
33%
Macular Degeneration
33%
Angiogenic Factor
33%